Articles

Last year, stem cell advocate Robert Klein was named the 2010 Biotech Humanitarian Honoree. Who will be named this year's Honoree?

Current rules resulting from a 2003 Office of Hearings and Appeals decision have inhibited and interfered with the growth and survival of small private biotechnology companies and the development of promising technologies and products

The Agriculture Department has announced additional money for loan guarantees to support construction of new advanced biofuel biorefineries.

The Maryland initiative’s 10-year plan helps build biotech access to funding

GEN's Editor-in-Chief John Sterling outlines his picks for the top ten "must attend" breakout sessions at the 2011 BIO International Convention.

As we celebrate World Health Day today, it is an opportunity to remember that vaccines represent one of the most important global health investments.

 John Carroll, editor of Fierce Biotech, shares what he won't miss at the 2011 BIO International Convention.

As Japan works to stabilize the crippled nuclear power plant in Fukushima, people are stocking up on potassium iodide tablets – one of the only drugs available to block the body's absorption of some radioactive materials.

President’s call for more funding comes as Congress focuses on reducing budget deficits.

Partnering decisions can make or break a company’s value. Pursuing the right partnership deal can ultimately increase a company’s value but conversely, the wrong decision can ultimately kill a company’ value.

Fifteen years after Dolly, the first mammal to be cloned from an adult cell rather than an embryo, made headlines, the process of livestock cloning is increasingly gaining acceptance as a viable means of satisfying demand for sustainable food production.

Introduction

Many of the products consumers purchase and use on a daily basis are made from petroleum, natural gas or petrochemicals. The availability and affordability of these products contributes to improved standards of living in countries around the world.

BIOtechNow’s Tracy Cooley discusses biotech in West Virginia – major growth areas, outlook for the future, and upcoming plans for the BIO International Convention – with Derek Gregg.

Patent systems can provide an advantage to society by rewarding the development of new inventions, promoting the advancement of technology and protecting the investor.  Patents often are the most important, and sometimes only, asset of a biotech company. Patents and related rights must be obtained in a timely and predictable manner and the ability to enforce those patents is critical.

Upward trends and investment opportunities will be focus of BIO’s World Congress in May.

Agricultural biotechnology can be a key element in the fight against hunger and malnutrition in the developing world.

The Massachusetts Life Sciences Center, which is tasked with administering the $1 billion state's life sciences initiative, has awarded five loans to start up companies, totaling $3.75 million.

Overhauled BIOTradeStatus lets users search for the latest information on hundreds of products.

Honoring the father of chemurgy, the award will be presented at the World Congress on Industrial Biotechnology and Bioprocessing in May.

Budget victories will help biotechnology in the Commonwealth

On March 9, the U.S. Senate Small Business and Entrepreneurship Committee voted 18-1 to pass the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Reauthorization Act of 2011 (S. 493). The bill includes provisions that would allow 25 percent of these grants to go to companies that are primarily backed by venture capital. The bill now goes to the full Senate. 

ISAAA data shows countries around the world have embraced agricultural biotechnology.

Bringing biotechs into global health R&D.